I’ve mentioned before that I’ve been on prednisone more than I’ve been off of it for the last few years. My latest stint with this drug started in early September, when a flare-up struck while on vacation, of course. I began with 30 milligrams, which is about an average dose for me to start feeling better, but I suffered for weeks as I gradually moved up to 40 and then 60 milligrams. My doctor told me that if the 60 milligrams didn’t work, he would need to start IV steroids. Luckily, 60 did the trick.
Then came the tapering. I dropped to 40 milligrams quite successfully, but started to flare again anytime I went below that. After weeks at that dose, I was able to move down to 30 milligrams, then to 20. By my last doctor’s appointment, I was desperate to get off the stuff.
Prednisone is a miracle drug. Within three or four days of taking my average starting dose, I usually feel much better. But I hate the side effects. My heart pounds. I can’t sleep. I sweat. This time around, I’ve gained weight, too, which is frustrating since I’m not eating much. I also have swelling and puffiness in my jawline and under my eyes.
I started lowering the prednisone about three weeks ago, and am happy to say that I’m down to 10 milligrams, soon to be 7.5. I can’t wait to be done. But at the same time, I’m worried. It never ends well when I go off prednisone. My symptoms usually come roaring back within a matter of weeks. Because I’ve started Stelara (
I just hope it’s later rather than sooner.
Note: IBD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of IBD News Today, or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to IBD.